Platelet-derived growth factor receptor beta
| GO Term | Evidence Code | Reference |
|---|---|---|
| angiogenesis | ||
| signal transduction | ||
| cell surface receptor protein tyrosine kinase signaling pathway | ||
| cell surface receptor protein tyrosine kinase signaling pathway | ||
| positive regulation of cell population proliferation |
| GO Term | Evidence Code | Reference |
|---|---|---|
| nucleus | ||
| cytoplasm | ||
| cytoplasm | ||
| Golgi apparatus |
|
|
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| protein kinase activity | ||
| protein kinase activity | ||
| protein tyrosine kinase activity | ||
| protein tyrosine kinase activity | ||
| platelet activating factor receptor activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 45 |
|
|
||
| 89 |
|
|
||
| 103 |
|
|
||
| 124 |
|
|
||
| 215 |
|
|||
| 230 |
|
|
||
| 292 |
|
|
||
| 307 |
|
|||
| 354 |
|
|
||
| 371 |
|
| Pathway Name | Organism |
|---|---|
| Constitutive Signaling by Aberrant PI3K in Cancer | Homo sapiens |
| Downstream signal transduction | Homo sapiens |
| PI3K/AKT Signaling | Homo sapiens |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | Homo sapiens |
| RAF/MAP kinase cascade | Homo sapiens |
| Signaling by PDGF | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:2226 | myeloproliferative neoplasm | |
| DOID:0080109 | infantile myofibromatosis | |
| DOID:0111344 | myeloproliferative disorder with eosinophilia | |
| DOID:4450 | renal cell carcinoma | |
| DOID:0060230 | basal ganglia calcification | |
| DOID:3068 | glioblastoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026